IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q2 2017 Holdings

Filed 2017-08-14 | 4 holdings | $8.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pendrell CorpCL A NEW70686R302$4.6K633,40054.2%
Onconova Therapeutics IncCOM NEW68232V306$2.2K997,02225.5%
MMA Cap Mgmt LLC(MMAC)COM55315D105$1.5K67,39918.2%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$176390,6242.1%